Next Article in Journal / Special Issue
The Activation Effect of Hainantoxin-I, a Peptide Toxin from the Chinese Spider, Ornithoctonus hainana, on Intermediate-Conductance Ca2+-Activated K+ Channels
Previous Article in Journal
Channel-Forming Bacterial Toxins in Biosensing and Macromolecule Delivery
Previous Article in Special Issue
Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb
Toxins 2014, 6(8), 2541-2567; doi:10.3390/toxins6082541
Review

Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential

1,†
,
1,5
,
2
,
2
,
2
,
1,3,*  and 1,4,*
Received: 4 June 2014 / Revised: 16 July 2014 / Accepted: 4 August 2014 / Published: 21 August 2014
(This article belongs to the Special Issue Antivenom and Venom Therapeutics)
View Full-Text   |   Download PDF [4302 KB, 25 August 2014; original version 21 August 2014]   |   Browse Figures

Abstract

Serum therapy remains the only specific treatment against envenoming, but anti-venoms are still prepared by fragmentation of polyclonal antibodies isolated from hyper-immunized horse serum. Most of these anti-venoms are considered to be efficient, but their production is tedious, and their use may be associated with adverse effects. Recombinant antibodies and smaller functional units are now emerging as credible alternatives and constitute a source of still unexploited biomolecules capable of neutralizing venoms. This review will be a walk through the technologies that have recently been applied leading to novel antibody formats with better properties in terms of homogeneity, specific activity and possible safety.
Keywords: scorpion stings; snakebite; antivenom; serum therapy; antibody; scFv; diabody; nanobody scorpion stings; snakebite; antivenom; serum therapy; antibody; scFv; diabody; nanobody
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Alvarenga, L.M.; Zahid, M.; Tommaso, A.D.; Juste, M.O.; Aubrey, N.; Billiald, P.; Muzard, J. Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential. Toxins 2014, 6, 2541-2567.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert